We are live on ! Find out more
DCM

DME Capital Management Portfolio holdings

AUM $3.19B
1-Year Est. Return 23.22%
This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
+23.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.04B
AUM Growth
-$140M
Cap. Flow
-$109M
Cap. Flow %
-5.33%
Top 10 Hldgs %
76.11%
Holding
45
New
3
Increased
6
Reduced
9
Closed
6

Top Buys

Rank Stock Value
1
HPQ icon
HP
HPQ
+$55.8M
2
VTRS icon
Viatris
VTRS
+$31.8M
3
CPRI icon
Capri Holdings
CPRI
+$24.8M
4
PTON icon
Peloton Interactive
PTON
+$24.3M
5
ODP
ODP
ODP
+$22.8M

Top Sells

Rank Stock Value
1
KD icon
Kyndryl
KD
+$52M
2
FCNCA icon
First Citizens BancShares
FCNCA
+$41.1M
3
LIVN icon
LivaNova
LIVN
+$39.2M
4
THC icon
Tenet Healthcare
THC
+$35.3M
5
AER icon
AerCap
AER
+$27.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 42.42%
2 Technology 15.68%
3 Healthcare 13.15%
4 Energy 12.96%
5 Financials 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LKFT
26
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.88B
$5.82M 0.28%
234,828
+75,000
+47% +$2.13M
TEVA icon
27
Teva Pharmaceuticals
TEVA
$42.5B
$5.28M 0.26%
324,850
GPRO icon
28
GoPro
GPRO
$107M
$4.01M 0.2%
2,823,100
GDX icon
29
VanEck Gold Miners ETF
GDX
$27.5B
$3.78M 0.18%
111,390
SHC icon
30
Sotera Health
SHC
$5.45B
$3.56M 0.17%
300,110
OIH icon
31
VanEck Oil Services ETF
OIH
$1.97B
$3.55M 0.17%
11,220
FCG icon
32
First Trust Natural Gas ETF
FCG
$651M
$1.86M 0.09%
70,830
DNMR
33
DELISTED
Danimer Scientific, Inc.
DNMR
$1.65M 0.08%
68,365
PDBC icon
34
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.66B
$1.65M 0.08%
117,360
TLIS
35
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$1.29M 0.06%
149,052
GANX icon
36
Gain Therapeutics
GANX
$87.9M
$725K 0.04%
566,130
NUVB icon
37
Nuvation Bio
NUVB
$2.24B
$102K 0.01%
34,995
NUVB.WS
38
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$16K ﹤0.01%
100,000
KPLTW
39
DELISTED
Katapult Holdings Warrant
KPLTW
$3.02K ﹤0.01%
262,227
AER icon
40
AerCap
AER
$23.5B
-319,050
Closed -$27.7M
CLVT icon
41
Clarivate
CLVT
$1.22B
-279,560
Closed -$2.08M
FCNCA icon
42
First Citizens BancShares
FCNCA
$25.4B
-25,160
Closed -$41.1M
KVUE icon
43
Kenvue
KVUE
$36.6B
-707,740
Closed -$15.2M
NPWR icon
44
NET Power
NPWR
$143M
-1,959,280
Closed -$22.3M
NBSE
45
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
-136,350
Closed -$61.3K

Similar funds

DME Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, DME Capital Management held 45 positions worth $2.04B, down 6.4% from $2.18B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

DME Capital Management withdrew a net $109M in Q2 2024, closing 6 positions and reducing 9 holdings. Its most notable exit was First Citizens BancShares, an estimated $41.1M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 42% of assets, up from 39% a quarter earlier, followed by Technology and Healthcare.

Against the trend, DME Capital Management opened a new position in Capri Holdings worth $22.7M.

  • DME Capital Management's largest Q2 2024 buy was Capri Holdings: 684,770 shares worth $22.7M.
  • DME Capital Management added most to HP in Q2 2024, an estimated $55.8M increase.
  • DME Capital Management's biggest Q2 2024 reduction was Kyndryl, cutting an estimated $52M.
  • DME Capital Management fully exited First Citizens BancShares in Q2 2024, selling an estimated $41.1M.
  • DME Capital Management's ten largest holdings make up 76% of its $2.04B portfolio in Q2 2024.
  • DME Capital Management opened 3 new positions and closed 6 in Q2 2024.
  • DME Capital Management's portfolio value fell 6.4% quarter-over-quarter to $2.04B.

Based on DME Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.